Yes, Tricare covers prescription drugs, including medications prescribed for a variety of conditions such as mental health disorders, chronic illnesses, and addiction treatments
BPC-157 is well-tolerated, with minimal side effects and no known toxicity
For 5-amino-1MQ specifically: Preclinical studies have not prominently described heart rate elevation as a dominant signal The mechanism (NNMT inhibition, NAD+ preservation) does not have the same direct cardiac implications as nuclear receptor agonism Human cardiovascular data at clinically relevant exposures are limited For physicians, the current evidence base does not support a major cardiovascular safety flag, but the limited human dataset means confident statements are premature
Its studied as a selective NNMT inhibitor in laboratory settings
From walking in, drawing blood, to talking with the nurse practitioner the treatment was second to none